Sign Up Today and Learn More About eClinicalWorks Stock
Invest in or calculate the value of your shares in eClinicalWorks or other pre-IPO companies through EquityZen's platform.
eClinicalWorks Stock (ECCW)
Ambulatory clinical information systems
About eClinicalWorks Stock
Founded
1999
Headquarters
Westborough, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
eClinicalWorks is a privately-held, leader in ambulatory clinical solutions. Its solutions extend the use of electronic health records beyond practice walls with the latest technologies and create community-wide records. The company has an established customer base of more than 50,000 providers and 225,000 plus medical professionals across all 50 states. Revenues for 2009 exceeded $100 million.
eClinicalWorks Press Mentions
Stay in the know about the latest news on eClinicalWorks
Large Primary Care Practice Achieves 50% Time Saving on Clinical Documentation with Sunoh.ai and eClinicalWorks
businesswire • Nov 07, 2024
Global Healthcare Cloud Computing Market Size, Share And Growth Analysis For 2024-2033
einpresswire • Nov 05, 2024
eClinicalWorks and Sunoh.ai Help Women’s Health Clinic Save Over Two Hours on Clinical Documentation Daily
businesswire • Aug 05, 2024
Aledade and eClinicalWorks Partner to Enhance Physician Experience through Ambient Listening Technology
globenewswire • Aug 05, 2024
Survey from eClinicalWorks Finds That AI Can Be an Antidote to Physician Burnout
businesswire • Aug 02, 2024
eClinicalWorks Management
Leadership team at eClinicalWorks
Technical Account Manager
Devharsh Trivedi
Sr. Project Manager - Implementation
Aman Thapar
Join now and verify your accreditation status to gain access to:
- eClinicalWorks current valuation
- eClinicalWorks stock price
- Available deals in eClinicalWorks and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in eClinicalWorks stock?
Accredited investors can buy pre-IPO stock in companies like eClinicalWorks through EquityZen funds. These investments are made available by existing eClinicalWorks shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell eClinicalWorks stock?
Shareholders can sell their eClinicalWorks stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
